Hexamethylmelamine (HEX) and melphalan (L-PAM) as second-line therapy in ovarian carcinoma

M. A. Tempero, A. Kessinger, H. M. Lemon

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Hexamethylmelamine (HEX) and melphalan (L-PAM) as second-line therapy in ovarian carcinoma'. Together they form a unique fingerprint.